Y S Hong Selected Research

Y S Hong Research Topics

Disease

6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2004
5	Neoplasms (Cancer) 01/2022 - 09/2004
2	Inflammation (Inflammations) 09/2020 - 02/2000
2	Disease Progression 01/2018 - 09/2004
2	Rectal Neoplasms (Rectal Cancer) 01/2016 - 07/2014
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 01/2014
2	Carcinogenesis 01/2014 - 09/2000
2	Body Weight (Weight, Body) 06/2009 - 11/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2001 - 01/2001
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2000 - 09/2000
2	Rheumatoid Arthritis 03/2000 - 02/2000
1	Axial Spondyloarthritis 09/2020
1	Uveitis 09/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2020
1	Fatigue 01/2018
1	Adenocarcinoma 01/2018
1	Anorexia 11/2015
1	Nausea 11/2015
1	Sacroiliitis 01/2015
1	Pneumothorax 06/2012
1	Neutropenia 02/2011
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2011
1	Hypoxia (Hypoxemia) 02/2010
1	Weight Gain 06/2009
1	Dehydration (Water Stress) 06/2009
1	Diarrhea 06/2009
1	Acidosis 06/2009
1	IGA Glomerulonephritis (IGA Nephropathy) 03/2009
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2006
1	Infections 10/2005
1	Opioid-Related Disorders (Opiate Addiction) 06/2005
1	Cancer Pain 06/2005
1	Pain (Aches) 06/2005
1	Adenocarcinoma of Lung 12/2004
1	Neoplasm Micrometastasis 12/2004
1	Stomach Neoplasms (Stomach Cancer) 09/2004
1	Thrombosis (Thrombus) 03/2001
1	Atherosclerosis 03/2001
1	Hyperplasia 03/2001
1	Pathologic Constriction (Stenosis) 03/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2001
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2001

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 12/2006 - 03/2000
2	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2016
2	C-Reactive ProteinIBA 01/2015 - 03/2000
2	Fluorouracil (Carac)FDA LinkGeneric 02/2011 - 09/2004
2	Proteins (Proteins, Gene)FDA Link 02/2010 - 01/2001
2	SteroidsIBA 03/2009 - 01/2000
2	Immunoglobulin G (IgG)IBA 03/2001 - 03/2000
2	AntibodiesIBA 03/2001 - 03/2000
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2001 - 02/2000
2	CytokinesIBA 01/2001 - 02/2000
1	binimetinibIBA 01/2022
1	encorafenibIBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 09/2020
1	nintedanibIBA 01/2018
1	MucinsIBA 01/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2016
1	Oxidoreductases (Dehydrogenase)IBA 11/2015
1	Simvastatin (Zocor)FDA LinkGeneric 11/2015
1	Coenzyme A (CoA)IBA 11/2015
1	Indicators and Reagents (Reagents)IBA 07/2014
1	ruxolitinibIBA 01/2014
1	Janus KinasesIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 05/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2011
1	ProdrugsIBA 02/2011
1	pimonidazoleIBA 02/2010
1	Spironolactone (Aldactone)FDA LinkGeneric 02/2010
1	Angiotensin IIIBA 02/2010
1	Enalapril FDA LinkGeneric 02/2010
1	AldosteroneIBA 02/2010
1	AlbuminsIBA 06/2009
1	Saline SolutionIBA 06/2009
1	LipidsIBA 11/2008
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2006
1	Complementary DNA (cDNA)IBA 10/2005
1	Opioid Analgesics (Opioids)IBA 06/2005
1	Morphine (MS Contin)FDA LinkGeneric 06/2005
1	Keratins (Keratin)IBA 12/2004
1	thiamine triphosphorate (TTP)IBA 09/2004
1	Capecitabine (Xeloda)FDA Link 09/2004
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2001
1	Phenobarbital (Luminal)FDA Link 03/2001
1	PlasminogenIBA 03/2001
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2001
1	CholesterolIBA 03/2001
1	Liposomes (Liposome)IBA 03/2001

Therapy/Procedure

6	Therapeutics 01/2022 - 09/2004
2	Radiotherapy 01/2018 - 02/2011
2	Chemoradiotherapy 01/2016 - 07/2014
2	Drug Therapy (Chemotherapy) 11/2015 - 02/2011
1	Catheters 06/2012
1	Chest Tubes (Chest Tube) 06/2012
1	Aftercare (After-Treatment) 06/2009
1	Length of Stay 06/2009
1	Oral Administration 11/2008
1	Pneumonectomy (Lung Volume Reduction) 12/2004
1	Heart Transplantation (Grafting, Heart) 03/2001
1	Transplantation 03/2001